The market is segmented into various products like scaffolds, tissue grafts, and others, with scaffolds holding the largest market share.
The tissue engineering market is also showing significant growth, with an estimated value expected to reach $8.9 billion by 2028, growing at a compound annual growth rate (CAGR) of 15.3%. The market is segmented into various products like scaffolds, tissue grafts, and others, with scaffolds holding the largest market share. This growth is primarily driven by the increasing need for regenerative medicines and continual technological advancements, including 3D printing and material innovation. North America currently holds the largest market share, but significant growth is expected in the Asia-Pacific region due to the increasing adoption of innovative technologies for treating chronic diseases​​.